Michael M. C. Lai

7.9k total citations · 1 hit paper
104 papers, 6.5k citations indexed

About

Michael M. C. Lai is a scholar working on Epidemiology, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Michael M. C. Lai has authored 104 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 39 papers in Molecular Biology and 39 papers in Animal Science and Zoology. Recurrent topics in Michael M. C. Lai's work include Animal Virus Infections Studies (39 papers), Hepatitis C virus research (33 papers) and Hepatitis B Virus Studies (32 papers). Michael M. C. Lai is often cited by papers focused on Animal Virus Infections Studies (39 papers), Hepatitis C virus research (33 papers) and Hepatitis B Virus Studies (32 papers). Michael M. C. Lai collaborates with scholars based in United States, Taiwan and South Korea. Michael M. C. Lai's co-authors include Stephanie T. Shi, Deborah R. Taylor, King-Song Jeng, Alexander E. Gorbalenya, Eugene V. Koonin, Patrick R. Romano, Glen N. Barber, Sugantha Govindarajan, Shinji Makino and Stephen A. Stohlman and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael M. C. Lai

104 papers receiving 6.3k citations

Hit Papers

Inhibition of the Interfe... 1999 2026 2008 2017 1999 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein
    1999 587 citations Deborah R. Taylor, Stephanie T. Shi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael M. C. Lai United States 48 2.6k 2.6k 1.9k 1.9k 1.5k 104 6.5k
Glenn Randall United States 36 2.4k 0.9× 1.5k 0.6× 1.2k 0.6× 2.6k 1.4× 411 0.3× 66 6.9k
Brett D. Lindenbach United States 40 4.7k 1.8× 4.9k 1.9× 2.5k 1.3× 2.7k 1.4× 539 0.4× 71 10.5k
William S. Mason United States 47 7.7k 2.9× 5.3k 2.1× 2.4k 1.3× 2.2k 1.2× 1.4k 0.9× 104 10.0k
Makoto Hijikata Japan 47 6.2k 2.3× 8.2k 3.2× 1.1k 0.6× 2.6k 1.4× 766 0.5× 111 10.6k
Kurt Bienz Switzerland 34 1.3k 0.5× 1.2k 0.5× 1.5k 0.8× 1.8k 1.0× 780 0.5× 70 4.8k
Christoph Seeger United States 38 5.6k 2.1× 4.0k 1.6× 1.9k 1.0× 1.8k 1.0× 564 0.4× 61 7.1k
Denise Egger Switzerland 33 1.2k 0.4× 1.2k 0.5× 1.5k 0.8× 1.7k 0.9× 756 0.5× 57 4.6k
MinKyung Yi United States 31 2.3k 0.9× 3.1k 1.2× 694 0.4× 2.5k 1.3× 452 0.3× 53 5.8k
Marc S. Collett United States 51 1.3k 0.5× 662 0.3× 2.5k 1.3× 3.3k 1.7× 1.5k 0.9× 112 8.3k
Ann D. Kwong United States 37 3.8k 1.5× 3.6k 1.4× 1.9k 1.0× 1.9k 1.0× 181 0.1× 70 6.6k

Countries citing papers authored by Michael M. C. Lai

Since Specialization
Citations

This map shows the geographic impact of Michael M. C. Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. C. Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. C. Lai more than expected).

Fields of papers citing papers by Michael M. C. Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. C. Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. C. Lai. The network helps show where Michael M. C. Lai may publish in the future.

Co-authorship network of co-authors of Michael M. C. Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. C. Lai. A scholar is included among the top collaborators of Michael M. C. Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. C. Lai. Michael M. C. Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Chih‐Hao, Yeh Chen, Wen‐Chi Su, et al.. (2024). Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants. Antiviral Research. 227. 105920–105920. 1 indexed citations
2.
Chao, Tai‐Ling, Sui‐Yuan Chang, Chih‐Hao Lu, et al.. (2023). Dual Effects of 3-epi-betulin from Daphniphyllum glaucescens in Suppressing SARS-CoV-2-Induced Inflammation and Inhibiting Virus Entry. International Journal of Molecular Sciences. 24(23). 17040–17040. 3 indexed citations
3.
Lai, Chao-Kuen, King-Song Jeng, Keigo Machida, & Michael M. C. Lai. (2008). Association of Hepatitis C Virus Replication Complexes with Microtubules and Actin Filaments Is Dependent on the Interaction of NS3 and NS5A. Journal of Virology. 82(17). 8838–8848. 91 indexed citations
4.
Aizaki, Hideki, et al.. (2006). Polypyrimidine-tract-binding Protein is a Component of the HCV RNA Replication Complex and Necessary for RNA Synthesis. Journal of Biomedical Science. 13(4). 469–480. 37 indexed citations
5.
Pavio, Nicole & Michael M. C. Lai. (2003). The hepatitis C virus persistence: how to evade the immune system?. Journal of Biosciences. 28(3). 287–304. 83 indexed citations
6.
Shi, Stephanie T., Stephen J. Polyak, Hong Tu, et al.. (2002). Hepatitis C Virus NS5A Colocalizes with the Core Protein on Lipid Droplets and Interacts with Apolipoproteins. Virology. 292(2). 198–210. 256 indexed citations
7.
Macnaughton, Thomas B. & Michael M. C. Lai. (2002). Genomic but Not Antigenomic Hepatitis Delta Virus RNA Is Preferentially Exported from the Nucleus Immediately after Synthesis and Processing. Journal of Virology. 76(8). 3928–3935. 40 indexed citations
8.
9.
Ning, Qin, Mingfeng Liu, Paul Kongkham, et al.. (1999). The Nucleocapsid Protein of Murine Hepatitis Virus Type 3 Induces Transcription of the Novel fgl2 Prothrombinase Gene. Journal of Biological Chemistry. 274(15). 9930–9936. 47 indexed citations
10.
Sheu, Gwo‐Tarng, et al.. (1998). Inhibition of Cellular RNA Polymerase II Transcription by Delta Antigen of Hepatitis Delta Virus. Virology. 247(2). 178–188. 25 indexed citations
11.
Hwang, Soon B., et al.. (1997). Hepatitis C Virus NS5B Protein Is a Membrane-Associated Phosphoprotein with a Predominantly Perinuclear Localization. Virology. 227(2). 439–446. 94 indexed citations
12.
Liao, Ching‐Len, Xuming Zhang, & Michael M. C. Lai. (1995). Coronavirus Defective-Interfering RNA as an Expression Vector: The Generation of a Pseudorecombinant Mouse Hepatitis Virus Expressing Hemagglutinin-Esterase. Virology. 208(1). 319–327. 29 indexed citations
13.
Yokomori, Kyoko, Miyuki Asanaka, Stephen A. Stohlman, et al.. (1995). Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. Journal of NeuroVirology. 1(5-6). 330–339. 23 indexed citations
14.
Liao, Ching‐Len & Michael M. C. Lai. (1995). A cis-Acting Viral Protein Is Not Required for the Replication of a Coronavirus Defective-Interfering RNA. Virology. 209(2). 428–436. 22 indexed citations
15.
Wang, Fun-In, John O. Fleming, & Michael M. C. Lai. (1992). Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity. Virology. 186(2). 742–749. 62 indexed citations
16.
Makino, S, et al.. (1988). Defective-interfering particles of murine coronavirus: Mechanism of synthesis of defective viral RNAs. Virology. 163(1). 104–111. 52 indexed citations
17.
Lai, Michael M. C.. (1987). Molecular Biology of Coronavirus 1986. Advances in experimental medicine and biology. 218. 7–13. 12 indexed citations
18.
Baric, Ralph S., Stephen A. Stohlman, Mahmood K. Razavi, & Michael M. C. Lai. (1985). Characterization of leader-related small RNAs in coronavirus-infected cells: Further evidence for leader-primed mechanism of transcription. Virus Research. 3(1). 19–33. 87 indexed citations
19.
Lien, Eric J., et al.. (1984). Novel N-hydroxyguanidine derivatives as anticancer and antiviral agents. Journal of Medicinal Chemistry. 27(2). 236–238. 93 indexed citations
20.
Wong, Timothy C., et al.. (1982). Class II defective avian sarcoma viruses: Comparative analysis of genome structure. Virology. 120(2). 453–464. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glenn Randall Breakdown of academic impact, for papers by Brett D. Lindenbach Breakdown of academic impact, for papers by William S. Mason Breakdown of academic impact, for papers by Makoto Hijikata Breakdown of academic impact, for papers by Kurt Bienz Breakdown of academic impact, for papers by Christoph Seeger Breakdown of academic impact, for papers by Denise Egger Breakdown of academic impact, for papers by MinKyung Yi Breakdown of academic impact, for papers by Marc S. Collett Breakdown of academic impact, for papers by Ann D. Kwong
Rankless by CCL
2026